UNC93B1 (Unc-93 Homolog B1) is a transmembrane endoplasmic reticulum (ER) protein that chaperones nucleic acid-sensing TLRs (TLR3, TLR7, TLR9, TLR11, TLR12, TLR13) to endolysosomes, enabling pathogen recognition and immune activation . Deficiency in UNC93B1 disrupts TLR trafficking, impairing cytokine responses and increasing susceptibility to infections like Leishmania major and herpes simplex encephalitis .
TLR Trafficking: UNC93B1 binds TLR3, TLR7, and TLR9 in the ER, stabilizing them and enabling transport to endosomes . A histidine-to-arginine mutation (H412R) in UNC93B1 disrupts this interaction, impairing antiviral responses .
Infection Models: UNC93B1 mutant mice exhibit heightened susceptibility to Leishmania major due to reduced IFN-γ and elevated IL-10. Rescue occurs via anti-IL-10R or recombinant IL-12 treatment .
Autoimmunity: Gain-of-function UNC93B1 variants (e.g., T93I, R336C) hyperactivate TLR7, driving lupus-like inflammation in mice and humans . Heterozygous mutations suffice to cause systemic autoimmunity .
Central Nervous System (CNS): UNC93B1 is expressed in microglia, neurons, and oligodendrocytes. It mediates neurotoxicity induced by microRNA let-7b via TLR7, implicating it in neurodegenerative diseases .
Therapeutic Targets: Blocking UNC93B1-TLR interactions could mitigate autoimmune disorders. Conversely, enhancing UNC93B1 function might bolster antiviral responses .
Biomarker Potential: Elevated UNC93B1 expression correlates with neuroinflammation and lupus nephritis .